EMILY KEBER: Open Payments
NPI 1396580700 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 70 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $475 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 9 | $229 |
| ABBVIE INC. | 7 | $183 |
| Vanda Pharmaceuticals Inc. | 5 | $123 |
| Noven Therapeutics, LLC | 6 | $111 |
| Alkermes, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Tris Pharma Inc | 4 | $83 |
| Corium, LLC | 8 | $73 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
Products named: REXULTI, VRAYLAR, Xelstrym, ARISTADA, TRINTELLIX, FANAPT, Azstarys, Auvelity.
Industry payments across FL — which companies pay providers there.
